You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

CLINICAL TRIALS PROFILE FOR MAZINDOL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for mazindol

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000277 ↗	Mazindol for Cocaine Abuse - 2	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1994-09-01	The purpose of this study is to evaluate high and low dose mazindol for cocaine abuse.
NCT00000277 ↗	Mazindol for Cocaine Abuse - 2	Completed	VA Connecticut Healthcare System	Phase 2	1994-09-01	The purpose of this study is to evaluate high and low dose mazindol for cocaine abuse.
NCT00000277 ↗	Mazindol for Cocaine Abuse - 2	Completed	Yale University	Phase 2	1994-09-01	The purpose of this study is to evaluate high and low dose mazindol for cocaine abuse.
NCT02808104 ↗	Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)	Completed	NLS Pharma Inc.	Phase 2	2016-08-01	The purpose of this study is to determine whether a controlled release formulation of mazindol is more effective than a placebo in the treatment of Attention Hyperactivity Disorder (ADHD) in adults.
NCT02808104 ↗	Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)	Completed	NLS Pharmaceutics	Phase 2	2016-08-01	The purpose of this study is to determine whether a controlled release formulation of mazindol is more effective than a placebo in the treatment of Attention Hyperactivity Disorder (ADHD) in adults.
NCT04923594 ↗	Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy	Recruiting	NLS Pharmaceutics	Phase 2	2021-09-13	This is a double-blind, randomized, placebo-controlled, multicenter trial of NLS-2 in adult patients with narcolepsy. The study will enroll approximately 60 patients and eligible patients will be treated to receive either NLS-2 or placebo for 4-weeks.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for mazindol

Condition Name

Chart
Table

Condition Name for mazindol
Intervention	Trials
Narcolepsy	2
Narcolepsy With Cataplexy	1
Narcolepsy Without Cataplexy	1
Attention Deficit Disorder With Hyperactivity	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for mazindol
Intervention	Trials
Cataplexy	2
Narcolepsy	2
Hyperkinesis	1
Disease	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for mazindol

Trials by Country

Map
Table

Trials by Country for mazindol
Location	Trials
United States	19
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for mazindol
Location	Trials
Texas	2
Michigan	2
Florida	2
South Carolina	1
Ohio	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for mazindol

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for mazindol
Clinical Trial Phase	Trials
Phase 2	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for mazindol
Clinical Trial Phase	Trials
Completed	2
Recruiting	1
Not yet recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for mazindol

Sponsor Name

Chart
Table

Sponsor Name for mazindol
Sponsor	Trials
NLS Pharmaceutics	3
NLS Pharma Inc.	1
National Institute on Drug Abuse (NIDA)	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for mazindol
Sponsor	Trials
Industry	4
Other	1
NIH	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.